Bibliographic citations
Congrains, A., Kamide, K., Oguro, R., Yasuda, O., Miyata, K., Yamamoto, E., Kawai, T., Kusunoki, H., Yamamoto, H., Takeya, Y., Yamamoto, K., Onishi, M., Sugimoto, k., Katsuya, T., Awata, N., Ikebe, K., Gondo, Y., Oike, Y., Ohishi, M., Rakugi, H. (2012). Genetic variants at the 9p21 locus contribute to atherosclerosis through modulation of ANRIL and CDKN2A/B [Tesis, Elsevier]. http://renati.sunedu.gob.pe/handle/sunedu/865093
Congrains, A., Kamide, K., Oguro, R., Yasuda, O., Miyata, K., Yamamoto, E., Kawai, T., Kusunoki, H., Yamamoto, H., Takeya, Y., Yamamoto, K., Onishi, M., Sugimoto, k., Katsuya, T., Awata, N., Ikebe, K., Gondo, Y., Oike, Y., Ohishi, M., Rakugi, H. Genetic variants at the 9p21 locus contribute to atherosclerosis through modulation of ANRIL and CDKN2A/B [Tesis]. JP: Elsevier; 2012. http://renati.sunedu.gob.pe/handle/sunedu/865093
@phdthesis{renati/1160,
title = "Genetic variants at the 9p21 locus contribute to atherosclerosis through modulation of ANRIL and CDKN2A/B",
author = "Rakugi, Hiromi",
publisher = "Elsevier",
year = "2012"
}
Genome-wide association studies (GWAS) have identified genetic variants contributing to the risk of cardiovascular disease (CVD) at the chromosome 9p21 locus. The CVD-associated region is adjacent to the two cyclin dependent kinase inhibitors (CDKN)2A and 2B and the last exons of the non-coding RNA, ANRIL. It is still not clear which of or how these transcripts are involved in the pathogenesis of atherosclerosis.
File | Description | Size | Format | |
---|---|---|---|---|
Congrains_Castillo_Ada.pdf | Artículo | 1.13 MB | Adobe PDF | View/Open |
Autorizacion.pdf Restricted Access | Formato de autorización | 1.18 MB | Adobe PDF | View/Open Request a copy |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.